J&J Medtech Appoints Kurt Van den Bosch As CFO
Executive Summary
Kurt Van den Bosch has been named CFO of J&J Medtech where he will report directly to Joe Wolk, J&J’s CFO.
You may also be interested in...
J&J To Split Consumer From Medtech and Pharmaceutical Businesses – Creating Two Companies To Unlock More Value, Growth, Innovation
Johnson & Johnson expects that the new J&J unit will be better positioned to share expertise such as combing medical devices with drugs and continue to innovate.
Minute Insight: Smith + Nephew Expands VR-based Surgical Training
Smith + Nephew is expanding its suite of simulation technologies to train surgeons on new techniques before they enter the operating room.
BTIG Analyst Zooms Into Alcon’s Revamp Into ‘Building A Pharma Company Inside A Device Company’
In his recent report on Alcon, BTIG analyst Ryan Zimmerman estimated that its pharmaceutical portfolio could generate close to $900m in fiscal year 2022.